Skip to content
Open access

ZFP36L2 orchestrates stress-adaptive plasticity in regeneration and cancer

Aug 2026 · Nature · Vol 657, pp. 1053 - 1063 · 0 citations · 86 references
Medicine

TL;DR

Together, these data show that ZFP36L2 acts as an important molecular switch that couples stress sensing with phenotypic plasticity, which in turn drives cellular dedifferentiation essential for re-establishing the ISC state during wound healing and metastasis.

Abstract

Phenotypic plasticity is a hallmark of cancer1; however the molecular switches required for cell-fate reprogramming are poorly understood. During intestinal wound-healing and colorectal cancer (CRC) metastasis, differentiated cells can dynamically dedifferentiate into an intestinal stem cell (ISC) state to drive epithelial regeneration and metastatic outgrowth2, 3, 4, 5, 6, 7, 8, 9–10. Here we show that the RNA-binding protein ZFP36L2, which is mutated in 5–10% of CRC11, 12, 13, 14–15, is a pivotal stress-responsive orchestrator of dynamic dedifferentiation. In mouse colon regeneration models, ZFP36L2 ablation inhibits dedifferentiation, ISC gene expression and function and impairs intestinal regeneration. In human CRC, loss of ZFP36L2 function abrogates metastatic seeding and the outgrowth of LGR5+ canonical metastases while promoting lineage plasticity and non-canonical differentiation into heterogeneous cell states. Mechanistically, ZFP36L2 binds to stress-associated mRNAs that contain AU-rich 3′ untranslated regions, which induces the formation of dynamic biomolecular condensates associated with mRNA degradation and termination of the stress response. Together, these data show that ZFP36L2 acts as an important molecular switch that couples stress sensing with phenotypic plasticity. This in turn drives cellular dedifferentiation essential for re-establishing the ISC state during wound healing and metastasis. In ZFP36L2-deficient CRC, the inability to re-enter the LGR5+ state during metastatic outgrowth promotes non-canonical lineage plasticity, which is associated with poor clinical outcomes. The RNA-binding protein ZFP36L2 mediates stress-adaptive plasticity in intestinal regeneration and colorectal cancer metastasis.

Read PDF

Similar papers

Review Open access Aug 2026

Oncofetal reprogramming and cellular plasticity in colorectal cancer: from mechanisms to clinical translation

The conceptual boundaries and operational criteria for identifying OnF in CRC are discussed, its regulatory mechanisms, plasticity-associated phenotypes, and translational relevance are examined, and the importance of distinguishing direct evidence of OnF from evidence of related plasticity mechanisms is emphasized.

Hao-Yu Wang, Song-Hao Liu, Ming-Xuan Zhang et al. · 0 citations
Review Sep 2026

BRN2 in Lineage Plasticity: A Prostate Cancer-Focused Perspective.

Lineage plasticity is a major mechanism by which prostate cancer adapts to therapeutic pressure, particularly following sustained inhibition of androgen receptor signaling. A central mediator of this process is BRN2, a POU3F2 neural lineage transcription factor that is normally suppressed in AR-dependent luminal prosta...

Fatemeh Seilani, Jia Peng, Meng Wu et al. · 0 citations
Open access Aug 2026

TUG1 supports mouse two-cell-stage development and ZGA-associated transcription through MAPK8 signaling

It is demonstrated that TUG1, which is highly expressed in tumors, regulates early embryonic development in mice and is transformed from a cancer-specific effector to a critical regulator of the ZGA, raising the possibility that related regulatory principles may operate in other biological contexts.

Jian-Wu Wang, Guang Yang, Qingbo Yang et al. · 0 citations
Review Open access Sep 2026

Cancer Stem Cell Quiescence: Molecular and Microenvironmental Evidence for an Actively Regulated Adaptive Survival Strategy

Cancer stem cells (CSCs) are a therapy‐refractory subpopulation that drives tumor persistence, recurrence, and metastasis. A defining characteristic of CSCs is their ability to reversibly exit the cell cycle and enter a quiescent state, thereby escaping cytotoxic therapies that primarily target proliferating cells. Alt...

Yasin Ahmadi, Trefa M. Abdullah, Sakhavat Abolhasani et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.